Imaging parameters at 24 hours
| . | As randomized . | As treated . | ||||
|---|---|---|---|---|---|---|
| Standard care, n = 73 . | Platelet transfusion, n = 80 . | P . | Standard care, n = 71 . | Platelet transfusion, n = 82 . | P . | |
| ICH growth > 6 mL, n (%) | 12 (16.4) | 27 (33.8) | .014 | 11 (15.5) | 28 (34.1) | .008 |
| Median ICH growth (IQR), mL | 1.2 (0.03-4.4) | 2.0 (0.3-9.1) | .081 | 0.9 (0.03-3.9) | 2.1 (0.3-9.3) | .033 |
| ICH growth, >6 mL or >33%, n (%) | 27 (37.0) | 39 (48.8) | .142 | 25 (35.2) | 41 (50.0) | .065 |
| Total lesion volume at 24 h (IQR), mL | 17.0 (11.0-55.2) | 31.7 (11.6-86.7) | .077 | 16.9 (10.7-55.2) | 31.1 (11.7-92.7) | .059 |
| PHE volume at 24 h (IQR), mL | 9.1 (4.1-21.1) | 13.8 (5.9-35.1) | .064 | 9.1 (4.0-21.8) | 13.6 (6.0-35.4) | .044 |
| PHE growth (IQR), mL | 5.7 (1.5-11.4) | 5.1 (2.0-20.5) | .538 | 5.4 (1.4-11.4) | 5.4 (2.1-20.6) | .342 |
| TLV growth (IQR), mL | 6.8 (1.8-15.5) | 7.9 (2.9-27.1) | .163 | 5.2 (1.2-14.9) | 8.5 (3.0-29.0) | .086 |
| New IVE, n (%) | 13 (17.8) | 17 (21.3) | .587 | 13 (18.3) | 17 (20.7) | .640 |
| rPHE 24 h (IQR) | 1.0 (0.6-1.6) | 0.9 (0.6-1.4) | .417 | 1.0 (0.6-1.5) | 0.9 (0.7-1.4) | .675 |
| . | As randomized . | As treated . | ||||
|---|---|---|---|---|---|---|
| Standard care, n = 73 . | Platelet transfusion, n = 80 . | P . | Standard care, n = 71 . | Platelet transfusion, n = 82 . | P . | |
| ICH growth > 6 mL, n (%) | 12 (16.4) | 27 (33.8) | .014 | 11 (15.5) | 28 (34.1) | .008 |
| Median ICH growth (IQR), mL | 1.2 (0.03-4.4) | 2.0 (0.3-9.1) | .081 | 0.9 (0.03-3.9) | 2.1 (0.3-9.3) | .033 |
| ICH growth, >6 mL or >33%, n (%) | 27 (37.0) | 39 (48.8) | .142 | 25 (35.2) | 41 (50.0) | .065 |
| Total lesion volume at 24 h (IQR), mL | 17.0 (11.0-55.2) | 31.7 (11.6-86.7) | .077 | 16.9 (10.7-55.2) | 31.1 (11.7-92.7) | .059 |
| PHE volume at 24 h (IQR), mL | 9.1 (4.1-21.1) | 13.8 (5.9-35.1) | .064 | 9.1 (4.0-21.8) | 13.6 (6.0-35.4) | .044 |
| PHE growth (IQR), mL | 5.7 (1.5-11.4) | 5.1 (2.0-20.5) | .538 | 5.4 (1.4-11.4) | 5.4 (2.1-20.6) | .342 |
| TLV growth (IQR), mL | 6.8 (1.8-15.5) | 7.9 (2.9-27.1) | .163 | 5.2 (1.2-14.9) | 8.5 (3.0-29.0) | .086 |
| New IVE, n (%) | 13 (17.8) | 17 (21.3) | .587 | 13 (18.3) | 17 (20.7) | .640 |
| rPHE 24 h (IQR) | 1.0 (0.6-1.6) | 0.9 (0.6-1.4) | .417 | 1.0 (0.6-1.5) | 0.9 (0.7-1.4) | .675 |
See Table 1 for expansion of abbreviations.